Arivin Therapeutics has been serving as the Finnish National Coordinator in the BEAM collaboration.
Arivin Therapeutics has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in September 2025.
Arivin Therapeutics's investors include Michiel Seerden, Business Finland.
Arivin Therapeutics is headquartered in Helsinki, Finland.
Arivin Therapeutics has been serving as the Finnish National Coordinator in the BEAM collaboration.
Arivin Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arivin Therapeutics — Funding & Investors." VCBacked, September 2, 2025, https://www.vcbacked.co/company/arivin-therapeutics. Accessed October 29, 2026.
VCBacked. (2025). Arivin Therapeutics — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/arivin-therapeutics
{{cite web |title=Arivin Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/arivin-therapeutics |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated